IRCT201309275623N10 IRCT 2013-10-07 Kashan University of Medical Sciences Effect of supplementation in treatment of polycystic ovary syndrome Effects of vitamin D and calcium co-supplementation on insulin resistance and lipid factor in overweight women with polycystic ovary syndrome 2013-10-02 anticipated 104 Complete https://irct.ir/trial/6040 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: To decrease potential confounding effects, all participants at study baseline and after stratification for pre-intervention BMI and age will be randomly allocated to take either supplement or placebo. Randomization will be done by the use of Stat Trek software, Blinding description: Randomization and allocation will be concealed from the researchers and participants until the final analyses are completed. Another person at the Clinic who is not involved in the trial and not aware of random sequences, will be assigned the participants to the numbered bottles of capsules. 3 Polycystic ovary syndrome. Intervention 1: Intervention group: Vitamin D perl and calcium capsule, 50000 IU and 1000 mg, weekly and daily, for 8 weeks orally. Intervention 2: Intervention group: Vitamin D perl, 50000 IU, weekly, for 8 weeks orally. Intervention 3: Intervention group: Calcium capsule, 1000 mg, daily, for 8 weeks orally. Intervention 4: Control group: Placebo capsule, daily, for 8 weeks orally. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Undecided - It is not yet known if there will be a plan to make this available